Professor Celia Marr recognised for commitment to veterinary profession
The BEVA has awarded an honorary membership to Celia Marr – internal medicine specialist at Rossdales Veterinary Surgeons and editor-in-chief of Equine Veterinary Journal – for her outstanding contributions to the equine veterinary profession.
Having previously held positions at the University of Cambridge Veterinary School, Valley Equine Hospital, Lambourn and the Royal Veterinary College, Professor Marr BVMS, MVM, PhD, DEIM, DipECEIM, FRCVS began working at Rossdales Equine Hospital and Diagnostic Centre in 2003 and received a Fellowship from the RCVS in 2016.
Professor Marr was instrumental in the founding of the European College of Equine Internal Medicine and its training programmes and was a founding trustee of the British College of Veterinary Surgeons.
Along with publishing more than 90 peer reviewed papers, she has contributed to books on equine medicine and has edited the leading equine cardiology text. She is a regular speaker at national and international meetings and congresses, and contributes to publications on equine welfare aimed at horse owners and trainers.
Lucy Grieve, president of BEVA said: “Celia’s contribution to the advancement of equine medicine in the UK is unsurpassed. Following in the footsteps of Dr Peter Rossdale as editor of the Equine Veterinary Journal, she has maintained the international reputation of BEVA’s flagship publication as the foremost veterinary publication focused solely on equines.
"She has also been highly influential in advancing the causes of evidence-based medicine, clinical audit and collaborative research within equine practice.”
Celia Marr added: “I am delighted to receive Honorary Membership of BEVA: I have thoroughly enjoyed my work with EVJ and BEVA. My role has often been as a co-ordinator so I’d like to take this opportunity to thank the huge number of academics and horse vets who contribute to EVJ as peer reviewers and authors and to recognise all those who have worked with me on educational and welfare initiatives.”
Image (c) Rossdales.
Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.
